BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 20332185)

  • 1. Genomics of cardiac remodeling in angiotensin II-treated wild-type and LOX-1-deficient mice.
    Kang BY; Hu C; Ryu S; Khan JA; Biancolella M; Prayaga S; Seung KB; Novelli G; Mehta P; Mehta JL
    Physiol Genomics; 2010 Jun; 42(1):42-54. PubMed ID: 20332185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rosuvastatin attenuates Ang II--mediated cardiomyocyte hypertrophy via inhibition of LOX-1.
    Kang BY; Mehta JL
    J Cardiovasc Pharmacol Ther; 2009 Dec; 14(4):283-91. PubMed ID: 19724024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LOX-1 dependent overexpression of immunoglobulins in cardiomyocytes in response to angiotensin II.
    Kang BY; Hu C; Prayaga S; Khaidakov M; Sawamura T; Seung KB; Mehta JL
    Biochem Biophys Res Commun; 2009 Feb; 379(2):395-9. PubMed ID: 19126408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin reduces angiotensin II-mediated cardiomyocyte growth via LOX-1 inhibition.
    Kang BY; Khan JA; Ryu S; Shekhar R; Seung KB; Mehta JL
    J Cardiovasc Pharmacol; 2010 Feb; 55(2):176-83. PubMed ID: 19935077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin reduces angiotensin II-mediated cardiomyocyte growth via LOX-1 inhibition.
    Kang BY; Khan JA; Ryu S; Shekhar R; Seung KB; Mehta JL
    J Cardiovasc Pharmacol; 2010 Apr; 55(4):417-24. PubMed ID: 20422739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-talk between inflammation and angiotensin II: studies based on direct transfection of cardiomyocytes with AT1R and AT2R cDNA.
    Wang X; Khaidakov M; Ding Z; Mitra S; Lu J; Liu S; Mehta JL
    Exp Biol Med (Maywood); 2012 Dec; 237(12):1394-401. PubMed ID: 23354398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of angiotensin II-mediated hypertension and cardiac remodeling by lectin-like oxidized low-density lipoprotein receptor-1 deletion.
    Hu C; Dandapat A; Sun L; Marwali MR; Inoue N; Sugawara F; Inoue K; Kawase Y; Jishage K; Suzuki H; Hermonat PL; Sawamura T; Mehta JL
    Hypertension; 2008 Sep; 52(3):556-62. PubMed ID: 18645046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nox2-containing NADPH oxidase and Akt activation play a key role in angiotensin II-induced cardiomyocyte hypertrophy.
    Hingtgen SD; Tian X; Yang J; Dunlay SM; Peek AS; Wu Y; Sharma RV; Engelhardt JF; Davisson RL
    Physiol Genomics; 2006 Aug; 26(3):180-91. PubMed ID: 16670255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 attenuates angiotensin II/salt-induced aortic remodeling.
    Weisberg AD; Albornoz F; Griffin JP; Crandall DL; Elokdah H; Fogo AB; Vaughan DE; Brown NJ
    Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):365-71. PubMed ID: 15576638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects.
    Masaki H; Kurihara T; Yamaki A; Inomata N; Nozawa Y; Mori Y; Murasawa S; Kizima K; Maruyama K; Horiuchi M; Dzau VJ; Takahashi H; Iwasaka T; Inada M; Matsubara H
    J Clin Invest; 1998 Feb; 101(3):527-35. PubMed ID: 9449684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of a novel intracrine mechanism in angiotensin II-induced cardiac hypertrophy.
    Baker KM; Chernin MI; Schreiber T; Sanghi S; Haiderzaidi S; Booz GW; Dostal DE; Kumar R
    Regul Pept; 2004 Aug; 120(1-3):5-13. PubMed ID: 15177915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin preconditioning of the heart: evidence for redox signaling.
    Das S; Engelman RM; Maulik N; Das DK
    Cell Biochem Biophys; 2006; 44(1):103-10. PubMed ID: 16456238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and functional remodeling of I(to) by angiotensin II in the mouse left ventricle.
    Tozakidou M; Goltz D; Hagenström T; Budack MK; Vitzthum H; Szlachta K; Bähring R; Ehmke H
    J Mol Cell Cardiol; 2010 Jan; 48(1):140-51. PubMed ID: 19744491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced vascular remodeling, endothelial dysfunction, and oxidative stress in resistance arteries of angiotensin II-infused macrophage colony-stimulating factor-deficient mice: evidence for a role in inflammation in angiotensin-induced vascular injury.
    De Ciuceis C; Amiri F; Brassard P; Endemann DH; Touyz RM; Schiffrin EL
    Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2106-13. PubMed ID: 16100037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. All-trans retinoic acid prevents angiotensin II- and mechanical stretch-induced reactive oxygen species generation and cardiomyocyte apoptosis.
    Choudhary R; Baker KM; Pan J
    J Cell Physiol; 2008 Apr; 215(1):172-81. PubMed ID: 17941088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction.
    Zhong J; Basu R; Guo D; Chow FL; Byrns S; Schuster M; Loibner H; Wang XH; Penninger JM; Kassiri Z; Oudit GY
    Circulation; 2010 Aug; 122(7):717-28, 18 p following 728. PubMed ID: 20679547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II induces vascular dysfunction without exacerbating blood pressure elevation in a mouse model of menopause-associated hypertension.
    Javeshghani D; Sairam MR; Neves MF; Schiffrin EL; Touyz RM
    J Hypertens; 2006 Jul; 24(7):1365-73. PubMed ID: 16794486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose and time-dependent apoptotic effects by angiotensin II infusion on left ventricular cardiomyocytes.
    Fabris B; Candido R; Bortoletto M; Zentilin L; Sandri M; Fior F; Toffoli B; Stebel M; Bardelli M; Belgrado D; Giacca M; Carretta R
    J Hypertens; 2007 Jul; 25(7):1481-90. PubMed ID: 17563572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactive oxygen species modulate angiotensin II-induced beta-myosin heavy chain gene expression via Ras/Raf/extracellular signal-regulated kinase pathway in neonatal rat cardiomyocytes.
    Shih NL; Cheng TH; Loh SH; Cheng PY; Wang DL; Chen YS; Liu SH; Liew CC; Chen JJ
    Biochem Biophys Res Commun; 2001 Apr; 283(1):143-8. PubMed ID: 11322781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pitavastatin, an HMG-CoA reductase inhibitor, exerts eNOS-independent protective actions against angiotensin II induced cardiovascular remodeling and renal insufficiency.
    Yagi S; Aihara K; Ikeda Y; Sumitomo Y; Yoshida S; Ise T; Iwase T; Ishikawa K; Azuma H; Akaike M; Matsumoto T
    Circ Res; 2008 Jan; 102(1):68-76. PubMed ID: 17967781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.